https://www.selleckchem.com/products/rbn-2397.html
lobal DR burden is expected to remain high through 2045, disproportionately affecting countries in the Middle East and North Africa and the Western Pacific. These updated estimates may guide DR screening, treatment, and public health care strategies.In developing countries, there is a need for low-cost neurobehavioral (N test batteries for vulnerable populations, particularly for children exposed to environmental neurotoxicants. The objective of the current study was to assess the feasibility and test-retest reliability of the Behavi
Like
Comment
Share
